Literature DB >> 1248472

Chemical modification as a probe of the topography and reactivity of horse-spleen apoferritin.

K Wetz, R R Crichton.   

Abstract

In apoferritin, but not in ferritin, 1.0 +/- 0.1 cysteine residue per subunit can be modified. In ferritin 3.3 +/- 0.3 lysine residues and 7.1 +/- 0.7 carboxyl groups per subunit can be modified, whilst the corresponding values for apoferritin are 4.4 +/- 0.4 lysine residues and 11.0 +/- 0.4 carboxyl groups per subunit. Modification of lysine residues which maleic anhydride and carboxyl groups with glycineamide in apoferritin which has been dissociated and denatured in guanidine hydrochloride leads to the introduction of 9.1 +/- 0.5 maleyl groups per subunit and 22.0 +/- 0.9 glycineamide residues per subunit. Whereas unmodified apoferritin subunit can be reassociated from guanidine hydrochloride to apoferritin monomer, the ability of maleylated apoferritin to reassociate is impaired. Apoferritin in which all the carboxyl groups have been blocked with glycineamide cannot be reassociated to apoferritin and exists in solution as stable subunits. The modification of one cysteine residue per subunit, of 3 or 4 lysine residues per subunit or of 7 carboxyl groups per subunit has no effect on the catalytic activity of apoferritin. In contrast the modification of 11 carboxyl groups per subunit completely abolishes the catalytic properties of the protein. We conclude that one or more carboxyl groups are essential for the catalytic activity of horse spleen apoferritin.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1248472     DOI: 10.1111/j.1432-1033.1976.tb10049.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  7 in total

Review 1.  Acidic phosphoproteins from bone matrix: a structural rationalization of their role in biomineralization.

Authors:  J P Gorski
Journal:  Calcif Tissue Int       Date:  1992-05       Impact factor: 4.333

2.  Chemical modification and structural analysis of the progesterone membrane binding protein from porcine liver membranes.

Authors:  E Falkenstein; C Eisen; K Schmieding; M Krautkrämer; C Stein; R Lösel; M Wehling
Journal:  Mol Cell Biochem       Date:  2001-02       Impact factor: 3.396

Review 3.  Potential of Ferritin-Based Platforms for Tumor Immunotherapy.

Authors:  Xiaoling Xu; Kewei Tian; Xuefang Lou; Yongzhong Du
Journal:  Molecules       Date:  2022-04-22       Impact factor: 4.927

4.  Evidence of H- and L-chains have co-operative roles in the iron-uptake mechanism of human ferritin.

Authors:  S Levi; S J Yewdall; P M Harrison; P Santambrogio; A Cozzi; E Rovida; A Albertini; P Arosio
Journal:  Biochem J       Date:  1992-12-01       Impact factor: 3.857

5.  Mutational analysis of the channel and loop sequences of human ferritin H-chain.

Authors:  S Levi; A Luzzago; F Franceschinelli; P Santambrogio; G Cesareni; P Arosio
Journal:  Biochem J       Date:  1989-12-01       Impact factor: 3.857

6.  Surface Modification of Protein Nanocontainers and Their Self-Directing Character in Polymer Blends.

Authors:  Merih Sengonul; Josef Ruzicka; Athula B Attygalle; Matthew Libera
Journal:  Polymer (Guildf)       Date:  2007-06-15       Impact factor: 4.430

Review 7.  Protein nanoparticles directed cancer imaging and therapy.

Authors:  Yao Miao; Tao Yang; Shuxu Yang; Mingying Yang; Chuanbin Mao
Journal:  Nano Converg       Date:  2022-01-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.